Vaxcyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	281.08	387.88	397.45	834.66	68.99	386.2
Short-Term Investments	1,430	1,359	682.78	96.72	176.99	-
Cash & Short-Term Investments	1,711	1,747	1,080	931.38	245.97	386.2
Cash Growth	-21.52%	61.75%	15.98%	278.65%	-36.31%	554.84%
Other Receivables	0.4	20.66	3.6	3.88	1.2	0.3
Receivables	0.4	20.66	3.6	3.88	1.2	0.3
Prepaid Expenses	55.45	15.73	6.16	5.31	9.18	2.5
Other Current Assets	-	4.38	5.97	1.99	-	-
Total Current Assets	1,767	1,788	1,096	942.56	256.35	389
Property, Plant & Equipment	337	270.15	110.62	31.65	35.91	3.27
Long-Term Investments	959.26	1,388	162.68	26.55	27.12	-
Long-Term Deferred Charges	-	-	-	-	0.5	0.1
Other Long-Term Assets	108.18	65.68	38.67	5.43	4.46	0.45
Total Assets	3,172	3,511	1,408	1,006	324.34	392.83
Accounts Payable	48.96	48.45	14.59	9.8	6.76	29.79
Accrued Expenses	145.31	85.84	123.64	24.82	16.68	17.06
Current Portion of Leases	5.77	5.89	7.11	5.91	5.28	-
Other Current Liabilities	-	-	-	-	-	0.01
Total Current Liabilities	200.05	140.18	145.34	40.53	28.72	46.86
Long-Term Leases	78.67	65.22	22.11	12.03	11.51	-
Other Long-Term Liabilities	-	0.1	-	0.01	0.1	0.12
Total Liabilities	278.72	205.5	167.45	52.57	40.32	46.98
Common Stock	0.13	0.13	0.1	0.08	0.06	0.05
Additional Paid-In Capital	4,800	4,698	2,165	1,476	582.84	544.35
Retained Earnings	-1,908	-1,388	-924.39	-522.13	-298.64	-198.56
Comprehensive Income & Other	0.86	-3.87	0.18	-0.36	-0.24	-
Total Common Equity	2,893	3,306	1,240	953.61	284.02	345.84
Shareholders' Equity	2,893	3,306	1,240	953.61	284.02	345.84
Total Liabilities & Equity	3,172	3,511	1,408	1,006	324.34	392.83
Total Debt	84.44	71.11	29.22	17.94	16.78	-
Net Cash (Debt)	1,627	1,676	1,051	913.44	229.19	386.2
Net Cash Growth	-24.42%	59.48%	15.06%	298.55%	-40.66%	556.63%
Net Cash Per Share	11.98	13.74	10.82	14.08	4.41	13.07
Filing Date Shares Outstanding	130.91	128.76	108.41	80.03	56.31	51.33
Total Common Shares Outstanding	130.03	124.89	95.36	79.47	53.03	51.07
Working Capital	1,567	1,648	950.62	902.03	227.63	342.14
Book Value Per Share	22.25	26.47	13.01	12.00	5.36	6.77
Tangible Book Value	2,893	3,306	1,240	953.61	284.02	345.84
Tangible Book Value Per Share	22.25	26.47	13.01	12.00	5.36	6.77
Machinery	-	58.15	35.62	15.12	11.5	5.25
Construction In Progress	-	151.79	51.82	-	-	0.22
Leasehold Improvements	-	4.38	1.46	1.35	-	1.9

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q